Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 9-13, January 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harris, P. E.
Right arrow Articles by Moore, M. A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harris, P. E.
Right arrow Articles by Moore, M. A. S.

Distinct Activities of Interferon-{gamma}, Lymphokine and Cytokine Differentiation-inducing Factors Acting on the Human Monoblastic Leukemia Cell Line U9371

Paul E. Harris2, Peter Ralph3, Patricia Litcofsky and Malcolm A. S. Moore

Department of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, New York 10021

The human monoblast leukemia line U937 is growth inhibited and induced to express various characteristics of mature monocytes by lymphokines (LK) and other cytokines. Previous experiments have shown that interferon-{gamma} (IFN-{gamma}) is responsible for some but not all of the differentiation-inducing effects on U937. To determine the variety and specificity of activity, the following factors were studied: phytohemagglutinin-induced LK that contained IFN-{gamma} (100 units/ml); purified IFN-{gamma}; human colony-stimulating factor 1 (CSF-1); and conditioned medium(a) (CM) from the human bladder carcinoma cell line 5637 and the hepatoma cell line SK-HEP. LK preparations contained no colony-stimulating activity, whereas CM from 5637 and SK-HEP both contained granulocyte-macrophage CSF (3000 to 4000 units/ml) but no IFN activity. IFN-{gamma} is the major immunoglobulin G Fc receptor-inducing species within lymphokine, since anti-interferon-{gamma} antibody inhibited most of this activity. Other sources of Fc receptor-inducing activity were CM from SK-HEP and 5637 cell lines. Human CSF-1 when tested up to 800 units/ml was inactive for Fc receptor induction. LK induced the chemotactic peptide receptor, but this induction was due to factors other than IFN-{gamma} as anti-IFN-{gamma} antibody did not inhibit the induction, and purified IFN-{gamma} at a dose equivalent to that found in LK (100 units/ml) had no activity in the assay. SK-HEP and 5637 CM had strong chemotactic peptide receptor-inducing activity, but human CSF-1 was inactive up to 800 units/ml. Peroxide production after stimulation with phorbol myristic acid could be induced by LK, LK with anti-IFN-{gamma} antibody, 5637, and SK-HEP treatment. IFN-{gamma} (100 units/ml) and CSF-1 (800 units/ml) were ineffective. Peroxide production was induced by IFN-{gamma} at concentrations above 1000 units/ml. The inducibility of several enzymatic activities was determined as additional measures of maturation. N-Acetylglucuronidase was induced, for example, by LK, IFN-{gamma}, 5637 CM, and phorbol myristic acid. Alkaline phosphatase was induced by LK, IFN-{gamma}, dexamethasone, and phorbol myristic acid. 1,25-Dihydroxycholecalciferol was also examined and could induce most of the maturational markers examined. The results demonstrate that non-IFN cytokines from several sources have profound differentiation-inducing effects on monoblast leukemia cells in a pattern different from that of IFN-{gamma}. The inducing factors in LK and nonlymphoid cytokines have similar biological activity on U937 cells, and the LK factor is not associated with CSF-1.

1 Supported in part by Grant CH-3F from the American Cancer Society and a grant from the Gar Reichman Foundation.

2 To whom requests for reprints should be addressed, at S1101, Department of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.

3 Present address: Cetus Corporation, 1400-53 Street, Emeryville, CA 94608.

Received 7/17/84. Accepted 9/12/84.




This article has been cited by other articles:


Home page
J. Immunol.Home page
E. A. Eklund and R. Kakar
Recruitment of CREB-Binding Protein by PU.1, IFN-Regulatory Factor-1, and the IFN Consensus Sequence-Binding Protein Is Necessary for IFN-{gamma}-Induced p67phox and gp91phox Expression
J. Immunol., December 1, 1999; 163(11): 6095 - 6105.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Spittler, R. Oehler, P. Goetzinger, S. Holzer, C. M. Reissner, F. Leutmezer, V. Rath, F. Wrba, R. Fuegger, G. Boltz-Nitulescu, et al.
Low Glutamine Concentrations Induce Phenotypical and Functional Differentiation of U937 Myelomonocytic Cells
J. Nutr., November 1, 1997; 127(11): 2151 - 2157.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
C. Shayo, C. Davio, A. Brodsky, A. G. Mladovan, B. L. Legnazzi, E. Rivera, and A. Baldi
Histamine Modulates the Expression of c-fos through Cyclic AMP Production via the H2 Receptor in the Human Promonocytic Cell Line U937
Mol. Pharmacol., June 1, 1997; 51(6): 983 - 990.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Takashima and M. Klagsbrun
Inhibition of Endothelial Cell Growth by Macrophage-like U-937 Cell-derived Oncostatin M, Leukemia Inhibitory Factor, and Transforming Growth Factor beta 1
J. Biol. Chem., October 4, 1996; 271(40): 24901 - 24906.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
T. Folks, J Justement, A Kinter, C. Dinarello, and A. Fauci
Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line
Science, November 6, 1987; 238(4828): 800 - 802.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.